cbioportal
cbioportal copied to clipboard
IGV 2.0
Customize IGV 2.0 to meet Patient and Study pages' needs
- [x] https://github.com/cbioportal/cbioportal/issues/5700
- [x] https://github.com/cbioportal/cbioportal/issues/4348
- [x] https://github.com/cbioportal/cbioportal/issues/4411
- [x] https://github.com/cbioportal/cbioportal/issues/4670
- [x] https://github.com/cbioportal/cbioportal/issues/4390
- [ ] https://github.com/cbioportal/cbioportal/issues/4410
- [ ] https://github.com/cbioportal/cbioportal/issues/1699
- [x] https://github.com/cbioportal/cbioportal/issues/5392
- [x] https://github.com/cbioportal/cbioportal/issues/5393
- [x] https://github.com/cbioportal/cbioportal/issues/5390
- [ ] https://github.com/cbioportal/cbioportal/issues/6646
- [ ] https://github.com/cbioportal/cbioportal/issues/6892
This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.
keep
This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.
unstale
#4348 seems like an easy target. #5700 and #6892 may be achieved without any change in the igv.js
library. Not sure if these 3 issues have high priority though.
#5390 might have been fixed already by the latest version of igv.js
Thanks, @onursumer. For the one that we need IGV support, I am wondering if they are all on IGV's to-do list?
@jjgao I am not sure if IGV team is prioritizing these features. Maybe we should offer some help? I don't know how feasible for us to involve in active IGV feature development though.
@onursumer I think we should identify our needs and communicate those to IGV. Maybe we should go through the issues by ourselves first and then talk to Jim?
This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.
This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.
This issue has been automatically marked as stale because it has not had recent activity. It will be closed if no further activity occurs. Thank you for your contributions.